| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034356455 |
| P356 | DOI | 10.1038/CR.2008.24 |
| P8608 | Fatcat ID | release_3ipr7yejk5bqndtge5wf7h2l54 |
| P698 | PubMed publication ID | 18270520 |
| P5875 | ResearchGate publication ID | 5580638 |
| P2093 | author name string | Shijie Sheng | |
| Hailong Wu | |||
| Yin-Yuan Mo | |||
| Daotai Nie | |||
| Fangting Wu | |||
| Shuomin Zhu | |||
| P2860 | cites work | Principles of microRNA-target recognition | Q21146368 |
| Akt phosphorylates and regulates Pdcd4 tumor suppressor protein | Q24298858 | ||
| Silencing of the Tropomyosin-1 gene by DNA methylation alters tumor suppressor function of TGF-beta | Q24302305 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion | Q24538826 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Vertebrate tropomyosin: distribution, properties and function | Q28216589 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth | Q28269583 | ||
| The biology and clinical relevance of the PTEN tumor suppressor pathway | Q28272157 | ||
| Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1) | Q28277655 | ||
| Tumor suppressive maspin and epithelial homeostasis | Q28285186 | ||
| The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation | Q28504536 | ||
| Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines | Q28975767 | ||
| Ribo-gnome: the big world of small RNAs | Q29615681 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| miRNAs, cancer, and stem cell division | Q29618925 | ||
| Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase | Q33220470 | ||
| A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas | Q33270040 | ||
| Regulation of microfilament organization and anchorage-independent growth by tropomyosin 1. | Q33706258 | ||
| MicroRNAs in cell proliferation, cell death, and tumorigenesis. | Q34497050 | ||
| Expression profiling identifies microRNA signature in pancreatic cancer | Q34588109 | ||
| MicroRNA biogenesis and cancer | Q36113847 | ||
| MicroRNA function: multiple mechanisms for a tiny RNA? | Q36325449 | ||
| MicroRNAs as oncogenes | Q36345302 | ||
| MicroRNA expression profiles in head and neck cancer cell lines | Q38302158 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity | Q38320085 | ||
| Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells | Q40141260 | ||
| Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors | Q40171554 | ||
| Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system | Q40291677 | ||
| PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. | Q40497377 | ||
| Expression and regulation of genes associated with cell death during murine preimplantation embryo development | Q48931238 | ||
| Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. | Q54614283 | ||
| MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior | Q57200299 | ||
| Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis | Q63753630 | ||
| P433 | issue | 3 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 350-359 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Cell Research | Q1524018 |
| P1476 | title | MicroRNA-21 targets tumor suppressor genes in invasion and metastasis | |
| P478 | volume | 18 |
| Q55647926 | A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma. |
| Q38688031 | A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer. |
| Q38720651 | A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens |
| Q33742015 | A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer |
| Q24649156 | A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis |
| Q53327783 | A sensitive SERS detection of miRNA using a label-free multifunctional probe. |
| Q36411472 | A six-microRNA set as prognostic indicators for bile duct cancer |
| Q52562647 | A step-by-step microRNA guide to cancer development and metastasis. |
| Q36199602 | A systems biology approach to defining metastatic biomarkers and signaling pathways |
| Q44481241 | A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma |
| Q37589125 | A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
| Q37148545 | A versatile microsatellite instability reporter system in human cells |
| Q89941044 | Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures |
| Q38072817 | Actin binding proteins: their ups and downs in metastatic life. |
| Q34443746 | Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene |
| Q55504759 | Advances of microRNAs correlated with invasion and metastasis of tumors |
| Q43277481 | Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol |
| Q35655840 | Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis |
| Q26998025 | Alterations of microRNAs contribute to colon carcinogenesis |
| Q39930107 | An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation |
| Q37952002 | An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis |
| Q37268606 | An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells. |
| Q35803441 | Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer |
| Q34326206 | Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN |
| Q89509558 | Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression |
| Q37290626 | Anti-cancer Therapies in High Grade Gliomas |
| Q38772085 | Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells |
| Q33692555 | Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. |
| Q37992691 | Apoptosis and microRNA aberrations in cancer |
| Q97595929 | Application of salivary noncoding microRNAs for the diagnosis of oral cancers |
| Q91716361 | Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs |
| Q38721982 | Argonaute 2 immunoprecipitation revealed large tumor suppressor kinase 1 as a novel proapoptotic target of miR-21 in T cells |
| Q37072748 | Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells |
| Q37661674 | Association of a peptoid ligand with the apical loop of pri-miR-21 inhibits cleavage by Drosha |
| Q38331260 | Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma |
| Q39869151 | BMP-6 inhibits microRNA-21 expression in breast cancer through repressing deltaEF1 and AP-1. |
| Q39020862 | Bio-barcode gel assay for microRNA. |
| Q28710308 | Bioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and Challenges |
| Q36204798 | Biologic characteristics of premalignant breast disease |
| Q24299613 | Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins |
| Q27694164 | Breast cancer epigenetics: from DNA methylation to microRNAs |
| Q37359847 | Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression |
| Q36737189 | Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes |
| Q39840008 | Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. |
| Q43123105 | Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression |
| Q42180067 | Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor. |
| Q38809756 | Catalytic Molecular Imaging of MicroRNA in Living Cells by DNA-Programmed Nanoparticle Disassembly |
| Q36316601 | Cell-free Circulating miRNA Biomarkers in Cancer |
| Q39540046 | Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells |
| Q36545604 | Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model |
| Q33737442 | Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells |
| Q90664798 | Circulating MicroRNAs as Potential Biomarkers for Lung Cancer |
| Q91018298 | Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer |
| Q89572854 | Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer |
| Q33867325 | Circulating microRNAs: novel biomarkers for esophageal cancer |
| Q28081347 | Circulating microRNAs: potential biomarkers for common malignancies |
| Q37673301 | Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma |
| Q41525878 | Comparative miRNA Expression Profile Analysis of Squamous Cell Carcinoma and Peritumoral Mucosa from the Meso- and Hypopharynx |
| Q38409303 | Consumption of Red/Processed Meat and Colorectal Carcinoma: Possible Mechanisms Underlying the Significant Association |
| Q38111225 | Control of metastatic progression by microRNA regulatory networks |
| Q84963968 | Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor |
| Q41601401 | Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study |
| Q38976705 | Coupling Aptamers to Short Interfering RNAs as Therapeutics. |
| Q53302549 | Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. |
| Q37378012 | Current molecular diagnostics of breast cancer and the potential incorporation of microRNA |
| Q34054835 | Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells |
| Q53293414 | DNA-templated in situ growth of AgNPs on SWNTs: a new approach for highly sensitive SERS assay of microRNA. |
| Q33517920 | Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation |
| Q33820667 | Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor |
| Q41837402 | Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications |
| Q36409368 | Detection of Exosomal miRNAs in the Plasma of Melanoma Patients |
| Q39995850 | Detection of N-(hexanoyl)lysine in the tropomyosin 1 protein in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat gastric cancer cells. |
| Q39048156 | Developing anti-neoplastic biotherapeutics against eIF4F. |
| Q57468209 | Differences in microRNA expression in breast cancer between women of African and European ancestry |
| Q36893304 | Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cells |
| Q35656643 | Differential MicroRNA Expression in Human Macrophages with Mycobacterium tuberculosis Infection of Beijing/W and Non-Beijing/W Strain Types |
| Q87401555 | Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status |
| Q39273744 | Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. |
| Q35684224 | Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum |
| Q34169891 | Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients |
| Q64120894 | Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines |
| Q42267974 | Differential microRNAs expression in serum of patients with lung cancer, pulmonary tuberculosis, and pneumonia. |
| Q39344864 | Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. |
| Q35204515 | Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization |
| Q33475535 | Discovering ligands for a microRNA precursor with peptoid microarrays |
| Q84962168 | Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins |
| Q47750291 | Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma. |
| Q41616542 | Downregulation of PDCD4 by miR-21 suppresses tumor transformation and proliferation in a nude mouse renal cancer model |
| Q35021340 | Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo |
| Q43053966 | Downregulation of miR-186 is associated with metastatic recurrence of gastrointestinal stromal tumors |
| Q43191223 | Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells |
| Q54672329 | Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. |
| Q33698660 | Dysregulated miR-183 inhibits migration in breast cancer cells. |
| Q41122951 | EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop |
| Q38891898 | Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines. |
| Q38971467 | Emerging role of microRNA-21 in cancer |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q34189668 | Endocrine disruptor regulation of microRNA expression in breast carcinoma cells |
| Q33792919 | Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability |
| Q34865437 | Epstein-Barr virus growth/latency III program alters cellular microRNA expression |
| Q39036600 | Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells |
| Q42844079 | Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer |
| Q37298620 | Estradiol-regulated microRNAs control estradiol response in breast cancer cells |
| Q90611608 | Evaluation of miR-22 and miR-21 as diagnostic biomarkers in patients with epithelial ovarian cancer |
| Q38849650 | Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells |
| Q37001437 | Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk |
| Q39084227 | Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents |
| Q38899793 | Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function. |
| Q26796590 | Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients |
| Q42730671 | Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma |
| Q36085903 | Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer |
| Q33454083 | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
| Q55261640 | Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer. |
| Q39045034 | From cell biology to immunology: Controlling metastatic progression of cancer via microRNA regulatory networks |
| Q37582019 | Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma |
| Q91992156 | GAS5/miR-21 Axis as a Potential Target to Rescue ZCL-082-Induced Autophagy of Female Germline Stem Cells In Vitro |
| Q92435781 | GLUT1-mediated effective anti-miRNA21 pompon for cancer therapy |
| Q39438566 | Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis |
| Q36845833 | Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cells |
| Q39602023 | Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics |
| Q35995713 | Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer |
| Q37552014 | Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors |
| Q36276762 | Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4. |
| Q64991270 | High-throughput chemical screening to discover new modulators of microRNA expression in living cells by using graphene-based biosensor. |
| Q24316045 | Holding their own: the noncanonical roles of Smad proteins |
| Q33991823 | Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells |
| Q52338368 | Hyaluronic acid functionalized nanostructured sensing interface for voltammetric determination of microRNA in biological media with ultra-high sensitivity and ultra-low fouling. |
| Q82893865 | Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs |
| Q36483432 | Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma |
| Q28259466 | Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma |
| Q37437619 | Identification of associations between small molecule drugs and miRNAs based on functional similarity |
| Q36316724 | Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma |
| Q39878140 | Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach |
| Q38688935 | Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer |
| Q37931898 | Implication of miRNA in the diagnosis and treatment of breast cancer. |
| Q34566039 | Important miRs of pathways in different tumor types |
| Q35919367 | Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma |
| Q24595630 | Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers |
| Q34537141 | Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets |
| Q39298822 | Infiltration related miRNAs in bladder urothelial carcinoma |
| Q33704284 | Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents |
| Q34433762 | Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival |
| Q36946688 | Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling |
| Q36755634 | Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition |
| Q36225884 | Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. |
| Q23909992 | Integrated analysis of dysregulated ncRNA and mRNA expression profiles in humans exposed to carbon nanotubes |
| Q28477824 | Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment |
| Q28251986 | Integrated genomic characterization of papillary thyroid carcinoma |
| Q35033649 | Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet |
| Q35106452 | Integrating mechanisms of pulmonary fibrosis |
| Q37267032 | Integrating the MicroRNome into the study of lung disease |
| Q33719798 | Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship |
| Q47097555 | Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma. |
| Q33891809 | Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. |
| Q34771731 | Involvement of microRNAs in lung cancer biology and therapy |
| Q47965128 | Kinetically modulated specificity against single-base mutants in nucleic acid recycling circuitry using the destabilization motif |
| Q85108036 | Knockdown of miR-21 as a Novel Approach for Leukemia Therapy |
| Q35029501 | Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth |
| Q39624836 | Knockdown of ribonuclease inhibitor expression with siRNA in non-invasive bladder cancer cell line BIU-87 promotes growth and metastasis potentials |
| Q28284772 | Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer |
| Q36782261 | Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction |
| Q97523764 | Leveraging Bayesian networks and information theory to learn risk factors for breast cancer metastasis |
| Q26824575 | Linking epithelial-to-mesenchymal-transition and epigenetic modifications |
| Q90701564 | LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis |
| Q30491599 | Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer |
| Q93264823 | Long non-coding RNA MEG3 suppresses the development of bladder urothelial carcinoma by regulating miR-96 and TPM1 |
| Q54091655 | Long noncoding RNA LINC01296 harbors miR-21a to regulate colon carcinoma proliferation and invasion. |
| Q35005629 | Lost in translation: an assessment and perspective for computational microRNA target identification |
| Q39223766 | MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. |
| Q39293814 | Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer. |
| Q26749037 | Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy |
| Q28109709 | Mechanisms and role of microRNA deregulation in cancer onset and progression |
| Q33804105 | Mechanisms of the epithelial-mesenchymal transition by TGF-beta |
| Q51889558 | Mesenchymal miR-21 regulates branching morphogenesis in murine submandibular gland in vitro. |
| Q35795725 | MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis |
| Q37373263 | Metastamir: the field of metastasis-regulatory microRNA is spreading |
| Q37806613 | Metastamirs: a stepping stone towards improved cancer management |
| Q28394526 | Metastasis suppressor genes at the interface between the environment and tumor cell growth |
| Q37799571 | Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis |
| Q35053495 | Methylation of an intronic region regulates miR-199a in testicular tumor malignancy |
| Q50953133 | MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. |
| Q34256676 | MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma |
| Q39420627 | MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. |
| Q52689430 | MiR-188-5p suppresses gastric cancer cell proliferation and invasion via targeting ZFP91. |
| Q39214783 | MiR-199b-5p targets HER2 in breast cancer cells |
| Q33703121 | MiR-200c Inhibits the Tumor Progression of Glioma via Targeting Moesin |
| Q39179399 | MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma |
| Q34960540 | MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor |
| Q34841931 | MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression |
| Q28283742 | MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis |
| Q33543185 | MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor |
| Q55282272 | MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer. |
| Q37313006 | MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells |
| Q89930631 | MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability |
| Q38341125 | MiRNA-451 plays a role as tumor suppressor in human glioma cells |
| Q27311645 | MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2 |
| Q37686230 | MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis |
| Q37407582 | MiRNAs and cancer |
| Q24318476 | Micro-RNA-21 regulates TGF-β-induced myofibroblast differentiation by targeting PDCD4 in tumor-stroma interaction |
| Q40423298 | Micro-RNA-31 controls hair cycle-associated changes in gene expression programs of the skin and hair follicle |
| Q37764166 | Micro-RNAs and breast cancer |
| Q33585105 | Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? |
| Q24336898 | MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators |
| Q64953093 | MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. |
| Q50060667 | MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer. |
| Q61999299 | MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer |
| Q39503268 | MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells |
| Q26752548 | MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment |
| Q35898407 | MicroRNA Involvement in Osteosarcoma |
| Q46052086 | MicroRNA Sequencing Data Analysis Toolkits |
| Q33994744 | MicroRNA and HER2-overexpressing cancer |
| Q36816367 | MicroRNA and cancer chemoprevention |
| Q37295059 | MicroRNA and cancer--focus on apoptosis |
| Q37988359 | MicroRNA and its roles in esophageal cancer. |
| Q38017596 | MicroRNA control of epithelial-mesenchymal transition and metastasis. |
| Q36037933 | MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review |
| Q37702742 | MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status |
| Q34835189 | MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis |
| Q35604297 | MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells |
| Q38971815 | MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer. |
| Q37249048 | MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine |
| Q33748980 | MicroRNA profiles discriminate among colon cancer metastasis |
| Q21195215 | MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer |
| Q38203140 | MicroRNA theragnostics for the clinical management of multiple myeloma. |
| Q96953902 | MicroRNA's - The vibrant performers in the oral cancer scenario |
| Q36819807 | MicroRNA-125a represses cell growth by targeting HuR in breast cancer |
| Q34311680 | MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. |
| Q38976478 | MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. |
| Q39214769 | MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas |
| Q24633326 | MicroRNA-182-5p targets a network of genes involved in DNA repair |
| Q33816470 | MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma |
| Q39551048 | MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. |
| Q36523888 | MicroRNA-205 increases the sensitivity of docetaxel in breast cancer |
| Q39283860 | MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. |
| Q39455098 | MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma |
| Q26851333 | MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis |
| Q37162427 | MicroRNA-21 as a potential colon and rectal cancer biomarker |
| Q21135545 | MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells |
| Q38070646 | MicroRNA-21 gene and cancer |
| Q38163908 | MicroRNA-21 in breast cancer: diagnostic and prognostic potential |
| Q38829415 | MicroRNA-21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features |
| Q46219037 | MicroRNA-21 in lung cancer: overexpression in metastasis of pulmonary adenocarcinomas and squamous cell carcinomas |
| Q35747354 | MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. |
| Q35070803 | MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. |
| Q33426268 | MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression |
| Q33783916 | MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling |
| Q43117122 | MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury |
| Q45330530 | MicroRNA-21 mediates the rapamycin-induced suppression of endothelial proliferation and migration |
| Q28117223 | MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFα |
| Q34426103 | MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration |
| Q34139065 | MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). |
| Q38802466 | MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway |
| Q58184215 | MicroRNA-21 promotes the proliferation and invasion of cholesteatoma keratinocytes |
| Q47159666 | MicroRNA-21 regulates Osteogenic Differentiation of Periodontal Ligament Stem Cells by targeting Smad5. |
| Q41412753 | MicroRNA-21 represses human cystathionine gamma-lyase expression by targeting at specificity protein-1 in smooth muscle cells. |
| Q36580732 | MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma |
| Q24633718 | MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4 |
| Q37930520 | MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases |
| Q36725131 | MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). |
| Q34211970 | MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo |
| Q36580396 | MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis |
| Q44718219 | MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. |
| Q36215852 | MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells |
| Q64915473 | MicroRNA-Based Diagnosis and Treatment of Metastatic Human Osteosarcoma. |
| Q52590673 | MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma. |
| Q50787878 | MicroRNA-Responsive Drug Release System for Selective Fluorescence Imaging and Photodynamic Therapy In Vivo. |
| Q93022677 | MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC) |
| Q37941371 | MicroRNA-mediated breast cancer metastasis: from primary site to distant organs |
| Q86748477 | MicroRNA: A New Player for Cancer Chemoprevention |
| Q42004179 | MicroRNA: Biogenesis, Function and Role in Cancer |
| Q37828424 | MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs |
| Q45873784 | MicroRNAs Reprogram Tumor Immune Response |
| Q38005062 | MicroRNAs and lung cancers: from pathogenesis to clinical implications |
| Q38064494 | MicroRNAs and lymphomagenesis: a functional review |
| Q38174308 | MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications |
| Q21195211 | MicroRNAs and their target gene networks in breast cancer |
| Q26862716 | MicroRNAs and triple negative breast cancer |
| Q36553661 | MicroRNAs as potential biomarkers in human solid tumors |
| Q38011943 | MicroRNAs as putative mediators of treatment response in prostate cancer |
| Q47994022 | MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential. |
| Q26823360 | MicroRNAs in breast cancer initiation and progression |
| Q38031835 | MicroRNAs in cancer treatment and prognosis. |
| Q37474280 | MicroRNAs in cancer: small molecules with a huge impact |
| Q37766206 | MicroRNAs in cardiac remodeling and disease |
| Q37894616 | MicroRNAs in colorectal cancer metastasis. |
| Q38215733 | MicroRNAs in human lung cancer. |
| Q34675280 | MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. |
| Q35033659 | MicroRNAs in skin and wound healing. |
| Q83429939 | MicroRNAs--the micro steering wheel of tumour metastases |
| Q36262854 | MicroRNAs: Potential biomarkers in cancer |
| Q26853284 | MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) |
| Q47811207 | MicroRNA‑141 inhibits epithelial‑mesenchymal transition, and ovarian cancer cell migration and invasion |
| Q38152548 | Microenvironmental regulation of cancer metastasis by miRNAs. |
| Q34674941 | Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo |
| Q36545873 | Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins |
| Q42548474 | Mild two-step method to construct DNA-conjugated silicon nanoparticles: scaffolds for the detection of microRNA-21. |
| Q38632040 | Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients. |
| Q34271727 | Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. |
| Q30486511 | Molecular assays for the detection of microRNAs in prostate cancer |
| Q28273857 | Myc-modulated miR-9 makes more metastases |
| Q28543184 | NMR characterization of an oligonucleotide model of the miR-21 pre-element |
| Q37219999 | Negative regulation of lncRNA GAS5 by miR-21. |
| Q39453653 | New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network. |
| Q38034670 | New NSAID targets and derivatives for colorectal cancer chemoprevention. |
| Q38089079 | New biomarkers for lung cancer |
| Q21296770 | Next-generation sequencing of microRNAs for breast cancer detection |
| Q39001832 | Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells |
| Q60958994 | Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication |
| Q94564507 | Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia |
| Q38667231 | Non-coding RNAs in Mammary Gland Development and Disease |
| Q33762263 | Non-coding RNAs: a key to future personalized molecular therapy? |
| Q37044600 | Noncanonical TGF-β signaling during mammary tumorigenesis |
| Q36571216 | Noncoding RNAs and Cancer. |
| Q26864697 | Noncoding RNAs in DNA repair and genome integrity |
| Q90183453 | Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis |
| Q47239413 | Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level |
| Q26773316 | Oncogenic MicroRNAs: Key Players in Malignant Transformation |
| Q34130311 | OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. |
| Q37634314 | Oncoviruses and Pathogenic MicroRNAs in Humans |
| Q34618415 | Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process |
| Q36756314 | Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse |
| Q44586187 | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis |
| Q34025404 | PAPD5-mediated 3' adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease. |
| Q90287006 | PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance |
| Q39418925 | PDCD4 expression inversely correlated with miR-21 levels in gastric cancers |
| Q33738854 | PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6. |
| Q42865116 | Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin |
| Q36165491 | Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion |
| Q41630132 | Placental Stem Villus Arterial Remodeling Associated with Reduced Hydrogen Sulfide Synthesis Contributes to Human Fetal Growth Restriction. |
| Q33572948 | Poly(A)-binding protein modulates mRNA susceptibility to cap-dependent miRNA-mediated repression |
| Q30632163 | Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. |
| Q53674278 | Post-transcriptional regulation by microrna-21 and let-7a microRNA in paediatric cholesteatoma. |
| Q33778961 | Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations |
| Q35376154 | Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation. |
| Q37902246 | Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer |
| Q34174271 | Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma |
| Q39150619 | Programmed cell death 4 mechanism of action: the model to be updated? |
| Q30557551 | Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance |
| Q37478933 | Progress in microRNA delivery |
| Q28394712 | RETRACTED ARTICLE: Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism |
| Q34075234 | RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells |
| Q39424688 | Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells |
| Q35754831 | Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs) |
| Q38161355 | Recent Advance in Biosensors for microRNAs Detection in Cancer |
| Q38449526 | Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging |
| Q91714772 | Recognizing and stabilizing miR-21 by chiral ruthenium(II) complexes |
| Q34283673 | Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort |
| Q36715870 | Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. |
| Q39756001 | Regulating A549 cells growth by ASO inhibiting miRNA expression |
| Q37895431 | Regulation and function of miRNA-21 in health and disease. |
| Q37259128 | Regulation of breast cancer and bone metastasis by microRNAs |
| Q38068926 | Regulation of breast cancer tumorigenesis and metastasis by miRNAs |
| Q35034340 | Regulation of cancer metastasis by cell-free miRNAs |
| Q37688816 | Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma |
| Q37148392 | Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN |
| Q38191102 | Regulation of microRNAs in cancer metastasis. |
| Q34988330 | Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma |
| Q53257500 | Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. |
| Q46040386 | Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia. |
| Q35956619 | Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells |
| Q34525461 | Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway |
| Q37454682 | Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II. |
| Q33694369 | Role of CSF-1 in progression of epithelial ovarian cancer |
| Q36205226 | Role of microRNA-21 and programmed cell death 4 in the pathogenesis of human uterine leiomyomas |
| Q36677690 | Role of microRNAs in breast cancer |
| Q57029561 | Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer |
| Q28941771 | SMAD proteins control DROSHA-mediated microRNA maturation |
| Q35757920 | STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. |
| Q39665695 | STAT5 induces miR-21 expression in cutaneous T cell lymphoma. |
| Q92550520 | Scenario and future prospects of microRNAs in gastric cancer: A review |
| Q35562046 | Selective inhibition of miR-21 by phage display screened peptide |
| Q33728084 | Selective release of microRNA species from normal and malignant mammary epithelial cells |
| Q36317309 | Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer |
| Q54322917 | Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. |
| Q35070602 | Shielding the messenger (RNA): microRNA-based anticancer therapies |
| Q35192383 | Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis |
| Q37133785 | Signal transduction in the development of pulmonary arterial hypertension |
| Q26827171 | Significance and therapeutic value of miRNAs in embryonal neural tumors |
| Q36768990 | Silibinin-Induced Apoptosis and Downregulation of MicroRNA-21 and MicroRNA-155 in MCF-7 Human Breast Cancer Cells |
| Q34425882 | Small players with big roles: microRNAs as targets to inhibit breast cancer progression |
| Q42170228 | Specific pomegranate juice components as potential inhibitors of prostate cancer metastasis |
| Q38849205 | Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. |
| Q90975660 | Stopping transformed cancer cell growth by rigidity sensing |
| Q37796192 | Strategies to identify microRNA targets: New advances |
| Q38017601 | Stromal biomarkers in breast cancer development and progression |
| Q27653464 | Structural basis for translational inhibition by the tumour suppressor Pdcd4 |
| Q36024500 | Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs |
| Q24647586 | Suppression of cell growth and invasion by miR-205 in breast cancer |
| Q33862088 | Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer |
| Q36490744 | Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology |
| Q34637817 | Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth |
| Q35008487 | Targeting miR-205 in breast cancer |
| Q38294147 | Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer |
| Q26830734 | The Akt-associated microRNAs |
| Q24657924 | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo |
| Q39202332 | The Process and Regulatory Components of Inflammation in Brain Oncogenesis |
| Q38529935 | The Role of miR-21 in Cancer |
| Q49593660 | The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets |
| Q90471098 | The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma |
| Q36416030 | The Type I IFN-Induced miRNA, miR-21 |
| Q39126198 | The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. |
| Q36337417 | The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. |
| Q28512635 | The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs |
| Q34220723 | The clinical potential of microRNAs |
| Q38694587 | The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer |
| Q37187237 | The complexity of microRNAs in human cancer |
| Q54997659 | The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform |
| Q30426792 | The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? |
| Q27022207 | The emerging molecular machinery and therapeutic targets of metastasis |
| Q34933986 | The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis |
| Q50496294 | The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. |
| Q39353707 | The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies |
| Q37768337 | The function of microRNAs, small but potent molecules, in human prostate cancer. |
| Q24608778 | The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 |
| Q38791765 | The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines. |
| Q38243969 | The miRNA network: micro-regulator of cell signaling in cancer |
| Q48682005 | The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. |
| Q37638140 | The microRNA network and tumor metastasis |
| Q38170025 | The microRNA networks of TGFβ signaling in cancer |
| Q35123062 | The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death |
| Q35172895 | The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis |
| Q37040558 | The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells |
| Q64104764 | The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma |
| Q33740551 | The real-time dynamic monitoring of microRNA function in cholangiocarcinoma |
| Q37766501 | The realm of microRNAs in cancers |
| Q37765520 | The role of MicroRNA in chemical carcinogenesis |
| Q38221290 | The role of miRNAs in cancer: from pathogenesis to therapeutic implications |
| Q34209973 | The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma |
| Q36396579 | The role of microRNAs in breast cancer migration, invasion and metastasis |
| Q36096641 | The role of microRNAs in colorectal cancer |
| Q37601781 | The role of microRNAs in endometriosis and associated reproductive conditions |
| Q35816884 | The roles of microRNAs in the regulation of tumor metastasis |
| Q37693586 | The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. |
| Q37438657 | The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation |
| Q47701015 | Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease |
| Q33780722 | Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model |
| Q28395179 | Therapeutic use of microRNAs in lung cancer |
| Q37822465 | Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers |
| Q92164237 | ToGo-WF: prediction of RNA tertiary structures and RNA-RNA/protein interactions using the KNIME workflow |
| Q35131885 | Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions |
| Q92711379 | Transregulation of microRNA miR-21 promoter by AP-1 transcription factor in cervical cancer cells |
| Q39449941 | Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration |
| Q64927427 | Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma. |
| Q36275252 | Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma |
| Q55094502 | Tropomyosin-1 promotes cancer cell apoptosis via the p53-mediated mitochondrial pathway in renal cell carcinoma. |
| Q37548937 | Tumor dormancy and metastasis. |
| Q33753966 | Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner |
| Q34998769 | Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma |
| Q40447202 | Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. |
| Q37258559 | Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. |
| Q34998307 | Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer |
| Q53309914 | Up-regulation of microRNA in bladder tumor tissue is not common. |
| Q41390518 | Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment |
| Q38342516 | hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations |
| Q34316535 | miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs |
| Q33966873 | miR-10b targets Tiam1: implications for Rac activation and carcinoma migration |
| Q37448717 | miR-139-5p is a regulator of metastatic pathways in breast cancer |
| Q89948121 | miR-142 induces accumulation of reactive oxygen species (ROS) by inhibiting pexophagy in aged bone marrow mesenchymal stem cells |
| Q24634704 | miR-145-mediated suppression of cell growth, invasion and metastasis |
| Q28275238 | miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway |
| Q28283590 | miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1 |
| Q33625493 | miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells |
| Q39436512 | miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells |
| Q21091183 | miR-200 enhances mouse breast cancer cell colonization to form distant metastases |
| Q55617722 | miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma. |
| Q35262736 | miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions |
| Q54280971 | miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer. |
| Q34288764 | miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer |
| Q33898669 | miR-21 inhibitor suppresses proliferation and migration of nasopharyngeal carcinoma cells through down-regulation of BCL2 expression |
| Q34285397 | miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer |
| Q38835514 | miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma |
| Q36369267 | miR-21 synergizes with BMP9 in osteogenic differentiation by activating the BMP9/Smad signaling pathway in murine multilineage cells |
| Q39483435 | miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells |
| Q34931601 | miR-21: a small multi-faceted RNA. |
| Q39749407 | miR-21: an oncomir on strike in prostate cancer. |
| Q39335411 | miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2. |
| Q34179800 | miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A. |
| Q35191816 | miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression |
| Q39917967 | miR-31: a master regulator of metastasis? |
| Q34787462 | miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8 |
| Q24613599 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis |
| Q34771896 | miRNA Biomarkers in Breast Cancer Detection and Management |
| Q34215056 | miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study |
| Q38186130 | miRNA expression profiles associated with diagnosis and prognosis in lung cancer |
| Q37643542 | miRNA-21 as a novel therapeutic target in lung cancer |
| Q26747138 | miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature Review |
| Q37750843 | miRNAs as molecular biomarkers of cancer |
| Q26824561 | miRNAs in breast cancer tumorigenesis (Review) |
| Q92208779 | miRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor |
| Q33629095 | microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells |
| Q28264087 | microRNA involvement in human cancer |
| Q38021509 | microRNA regulation of cell viability and drug sensitivity in lung cancer |
| Q33703585 | microRNA, cell cycle, and human breast cancer |
| Q36642611 | microRNA-1301-mediated inhibition of tumorigenesis |
| Q36424194 | microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer |
| Q37587348 | microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2. |
| Q34257789 | microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion |
| Q37760459 | microRNAs and EMT in mammary cells and breast cancer. |
| Q50544691 | microRNAs and Endometrial Pathophysiology. |
| Q35185340 | microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis |
| Q37784515 | microRNAs: Master Regulators as Potential Therapeutics in Cancer |
| Q34832663 | microRNAs: short non-coding bullets of gain of function mutant p53 proteins |
Search more.